CVM 8.90 ▲ 3.13% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    CEL-SCI Corporation

    AMEX: CVM · Real-Time Price · USD
    8.90
    0.27 (3.13%)
    At close: Sep 24, 2025, 3:59 PM
    8.71
    -2.19%
    After-hours: Sep 24, 2025, 07:56 PM EDT
    3.13%
    Bid 8.63
    Market Cap 61.29M
    Revenue (ttm) 5.95M
    Net Income (ttm) -25.42M
    EPS (ttm) -9.13
    PE Ratio (ttm) -0.98
    Forward PE -3.2
    Analyst n/a
    Dividends n/a
    Ask 9.15
    Volume 58,952
    Avg. Volume (20D) 806,080
    Open 8.79
    Previous Close 8.63
    Day's Range 8.73 - 9.10
    52-Week Range 1.98 - 33.90
    Beta 0.55
    Ex-Dividend Date n/a

    About CVM

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol CVM
    Website n/a
    Full Company Profile
    4 weeks ago
    -28.6%
    CEL-SCI shares are trading lower after the company... Unlock content with Pro Subscription
    2 months ago
    -22.93%
    CVM stock has given up its prior gain. CEL-SCI shares were trading higher after the company announced it signed a partnership with a Saudi Arabian pharma and healthcare company.
    news image

    3 weeks ago · businesswire.com

    CEL-SCI Announces Closing of $10 Million Public Offering

    VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI announces closing of $10 million public offering.

    news image

    4 weeks ago · businesswire.com

    CEL-SCI Announces Pricing of $10 Million Public Offering

    VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI announces pricing of $10 million public offering.

    news image

    4 weeks ago · businesswire.com

    CEL-SCI Announces Proposed Public Offering

    VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI announces proposed public offering.

    news image

    1 month ago · businesswire.com

    CEL-SCI Reports Fiscal Third Quarter 2025 Financial Results

    VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI reports fiscal third quarter 2025 financial results.

    news image

    1 month ago · businesswire.com

    CEL-SCI's Multikine Head and Neck Cancer Immunotherapy Breakthrough Medicine Designation Filed in Saudi Arabia: Allows for Patient Access and Reimbursement/Sale Upon Granting of the Designation Which Takes Approximately 60 Days Based on SFDA Timeline

    VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI's Multikine Head and Neck Cancer Immunotherapy Breakthrough Medicine Designation Filed in Saudi Arabia.

    news image

    2 months ago · businesswire.com

    CEL-SCI Announces Closing of $5.7 Million Offering Priced At-The-Market Under NYSE American Rules

    VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI announces closing of $5.7 million offering priced at-the-market under NYSE American rules.

    news image

    2 months ago · businesswire.com

    CEL-SCI to Sign Partnership Agreement With Leading Saudi Arabian Pharma Company for Multikine in the Treatment of Head & Neck Cancer

    VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI to sign partnership agreement with leading Saudi Arabian pharma company for Multikine in the treatment of head & neck cancer.

    Add to Watchlist